Literature DB >> 11409891

APC senses cell-cell contacts and moves to the nucleus upon their disruption.

M G Brocardo1, M Bianchini, M Radrizzani, G B Reyes, A V Dugour, G L Taminelli, C Gonzalez Solveyra, T A Santa-Coloma.   

Abstract

The adenomatous polyposis coli (APC) tumor suppressor protein is involved in the Wnt/wingless pathway, modulating beta-catenin activity. We report the development of a highly specific, chemically synthesized oligobody (oligonucleotide-based synthetic antibody), directed against the N-terminal region of APC. Using this reagent, we found that within 16 h of disrupting HT-29 cell-cell contacts by harvesting cells with trypsin/EDTA treatment and replating, APC was translocated from the cytoplasm to the nucleus. Five days after plating the cells, when the cells had returned to their normal confluent phenotype and cell-cell contacts were reestablished, APC returned to the cytoplasm. These results suggest that APC functions as part of a "sensor" system, and responds to the loss of cell-cell contacts by moving to the nucleus, and returning to the cytoplasm when the contacts are fully restored. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11409891     DOI: 10.1006/bbrc.2001.5066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  The ins and outs of APC and beta-catenin nuclear transport.

Authors:  Beric R Henderson; Francois Fagotto
Journal:  EMBO Rep       Date:  2002-09       Impact factor: 8.807

2.  Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.

Authors:  Athamassios Kotsinas; Konstantinos Evangelou; Panayotis Zacharatos; Christos Kittas; Vassilis G Gorgoulis
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Redefining the subcellular location and transport of APC: new insights using a panel of antibodies.

Authors:  Mariana Brocardo; Inke S Näthke; Beric R Henderson
Journal:  EMBO Rep       Date:  2005-02       Impact factor: 8.807

Review 4.  Anp32e (Cpd1) and related protein phosphatase 2 inhibitors.

Authors:  Tomás A Santa-Coloma
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

5.  Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation.

Authors:  Timothy A Chan; Zhenghe Wang; Long H Dang; Bert Vogelstein; Kenneth W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

6.  A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies.

Authors:  Benjamin Ribba; Thierry Colin; Santiago Schnell
Journal:  Theor Biol Med Model       Date:  2006-02-10       Impact factor: 2.432

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.